Genetic testing could prevent three-quarters of avoidable side effects of some medicines, study suggests Researchers found that patients experiencing adverse drug reactions to treatments for psychiatric disorders and cardiovascular problems could benefit the most from personalised prescribing with pharmacogenomics.…
Medication maths: calculations involving molecular weight This article is part of a comprehensive series on pharmaceutical calculations in preparation for the General Pharmaceutical Council registration assessment. It provides guidance on how to tackle questions that involve calculations based on molecular weight, including a worked example of a sample exa…
Only 15% of NHS trusts meet emergency department pharmacy support standards, investigation finds Exclusive: Freedom of information requests showed that only 15 of 98 NHS trusts in England met Royal College of Emergency Medicine and UK Clinical Pharmacy Association recommendations on pharmacy staffing levels.…
Case-based learning: nutrition and feeding considerations for hospitalised neonates When neonates are faced with feeding constraints, it is important that pharmacists work effectively within the multidisciplinary team to improve decision-making and provide effective support for mothers and families.…
Rapid on-site genetic sequencing could help curb antimicrobial-resistant outbreaks, says MHRA Researchers found that rapid on-site genetic sequencing detects bacterial infections within two days, which is “significantly faster“ than traditional methods.…
Nine in ten people would accept a pharmacogenomics test, reveals survey The majority of respondents to a survey said they would be motivated to take a pharmacogenomics test to enhance drug effectiveness and reduce the risk of adverse drug reactions.…
How an MPharm placement in social care is preparing students for real-world roles Pharmacist educators in Manchester explain the value brought to students by a residential nursing home placement within the MPharm programme.…
Pharmacogenomics trial expands across England Programme co-ordinators are aiming to recruit a further 1,450 people to the second phase of the PROGRESS trial, which is the first in the UK to introduce genetic testing before prescribing in primary care.…
NICE approves gene-editing sickle cell therapy for NHS in England Exagamglogene autotemcel, also known as exa-cel, is now recommended for NHS use, reversing previous draft guidance.…
Engineering precision: developing the next generation of antibody drug conjugates Researchers are working to create a new generation of these targeted cancer therapies to improve efficacy and minimise off-target adverse effects.…
